IL111775A - Prolyl endopeptidase inhibitors, their preparation and compositions containing same - Google Patents
Prolyl endopeptidase inhibitors, their preparation and compositions containing sameInfo
- Publication number
- IL111775A IL111775A IL111775A IL11177594A IL111775A IL 111775 A IL111775 A IL 111775A IL 111775 A IL111775 A IL 111775A IL 11177594 A IL11177594 A IL 11177594A IL 111775 A IL111775 A IL 111775A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- mmol
- formula
- compounds
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16110693A | 1993-12-02 | 1993-12-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL111775A0 IL111775A0 (en) | 1995-01-24 |
| IL111775A true IL111775A (en) | 1998-06-15 |
Family
ID=22579844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL111775A IL111775A (en) | 1993-12-02 | 1994-11-27 | Prolyl endopeptidase inhibitors, their preparation and compositions containing same |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5661167A (OSRAM) |
| EP (1) | EP0731788B1 (OSRAM) |
| JP (1) | JPH09506090A (OSRAM) |
| KR (1) | KR100341982B1 (OSRAM) |
| CN (1) | CN1136806A (OSRAM) |
| AT (1) | ATE223894T1 (OSRAM) |
| AU (1) | AU684861B2 (OSRAM) |
| CA (1) | CA2177821C (OSRAM) |
| DE (1) | DE69431359T2 (OSRAM) |
| DK (1) | DK0731788T3 (OSRAM) |
| ES (1) | ES2179093T3 (OSRAM) |
| HU (1) | HUT74687A (OSRAM) |
| IL (1) | IL111775A (OSRAM) |
| NO (1) | NO962238D0 (OSRAM) |
| NZ (1) | NZ276600A (OSRAM) |
| PT (1) | PT731788E (OSRAM) |
| TW (1) | TW280818B (OSRAM) |
| WO (1) | WO1995015310A1 (OSRAM) |
| ZA (1) | ZA949302B (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| EP1620091B1 (en) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
| EP1824846A2 (en) | 2003-11-03 | 2007-08-29 | Probiodrug AG | Novel compounds for the treatment of neurological disorders |
| ZA200603165B (en) | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| KR101099206B1 (ko) | 2004-02-05 | 2011-12-27 | 프로비오드룩 아게 | 신규한 글루타미닐 시클라제 저해제 |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
| ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| US8524654B2 (en) * | 2007-05-21 | 2013-09-03 | The Uab Research Foundation | Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation |
| PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| EA022420B1 (ru) | 2010-03-10 | 2015-12-30 | Пробиодруг Аг | Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5) |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
| WO2015116590A1 (en) | 2014-01-28 | 2015-08-06 | Spirit Global Energy Solutions, Inc. | Down-hole gas and solids separator utilized in production hydrocarbons |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
| IL77748A (en) * | 1985-02-04 | 1991-11-21 | Merrell Dow Pharma | Amino acid and peptide derivatives as peptidase inhibitors |
| DE3712365A1 (de) * | 1987-04-11 | 1988-10-27 | Hoechst Ag | Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung |
| US4855303A (en) * | 1987-07-01 | 1989-08-08 | Pfizer Inc. | Fluorine containing renin inhibitors |
| JPH0662591B2 (ja) * | 1988-12-14 | 1994-08-17 | 株式会社ヤクルト本社 | 新規なチオプロリン誘導体 |
| WO1990012005A1 (fr) * | 1989-04-13 | 1990-10-18 | Japan Tobacco Inc. | Nouveaux derives aminoacides possedant une activite d'inhibiteur de la prolylendopeptidase |
-
1994
- 1994-11-08 DE DE69431359T patent/DE69431359T2/de not_active Expired - Fee Related
- 1994-11-08 AU AU10917/95A patent/AU684861B2/en not_active Ceased
- 1994-11-08 NZ NZ276600A patent/NZ276600A/en unknown
- 1994-11-08 PT PT95901820T patent/PT731788E/pt unknown
- 1994-11-08 HU HU9601472A patent/HUT74687A/hu unknown
- 1994-11-08 CA CA002177821A patent/CA2177821C/en not_active Expired - Fee Related
- 1994-11-08 JP JP7515618A patent/JPH09506090A/ja not_active Ceased
- 1994-11-08 WO PCT/US1994/012865 patent/WO1995015310A1/en not_active Ceased
- 1994-11-08 AT AT95901820T patent/ATE223894T1/de not_active IP Right Cessation
- 1994-11-08 CN CN94194374A patent/CN1136806A/zh active Pending
- 1994-11-08 EP EP95901820A patent/EP0731788B1/en not_active Expired - Lifetime
- 1994-11-08 KR KR1019960702894A patent/KR100341982B1/ko not_active Expired - Fee Related
- 1994-11-08 ES ES95901820T patent/ES2179093T3/es not_active Expired - Lifetime
- 1994-11-08 DK DK95901820T patent/DK0731788T3/da active
- 1994-11-23 ZA ZA949302A patent/ZA949302B/xx unknown
- 1994-11-24 TW TW083110932A patent/TW280818B/zh active
- 1994-11-27 IL IL111775A patent/IL111775A/en not_active IP Right Cessation
-
1996
- 1996-05-31 NO NO962238A patent/NO962238D0/no not_active Application Discontinuation
- 1996-12-02 US US08/759,323 patent/US5661167A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1136806A (zh) | 1996-11-27 |
| EP0731788B1 (en) | 2002-09-11 |
| CA2177821A1 (en) | 1995-06-08 |
| HUT74687A (en) | 1997-01-28 |
| PT731788E (pt) | 2003-01-31 |
| IL111775A0 (en) | 1995-01-24 |
| WO1995015310A1 (en) | 1995-06-08 |
| DE69431359T2 (de) | 2003-07-31 |
| AU1091795A (en) | 1995-06-19 |
| ES2179093T3 (es) | 2003-01-16 |
| NO962238L (no) | 1996-05-31 |
| JPH09506090A (ja) | 1997-06-17 |
| TW280818B (OSRAM) | 1996-07-11 |
| ZA949302B (en) | 1995-08-07 |
| NZ276600A (en) | 1997-09-22 |
| ATE223894T1 (de) | 2002-09-15 |
| HU9601472D0 (en) | 1996-07-29 |
| DK0731788T3 (da) | 2003-01-20 |
| KR100341982B1 (ko) | 2002-11-30 |
| NO962238D0 (no) | 1996-05-31 |
| US5661167A (en) | 1997-08-26 |
| CA2177821C (en) | 2000-03-28 |
| DE69431359D1 (de) | 2002-10-17 |
| EP0731788A1 (en) | 1996-09-18 |
| AU684861B2 (en) | 1998-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0731788B1 (en) | Prolyl endopeptidase inhibitors | |
| US4692458A (en) | Anti-hypertensive agents | |
| US5496927A (en) | Peptidase inhibitors | |
| US5510369A (en) | Pyrrolidine thrombin inhibitors | |
| EP0073143B1 (en) | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | |
| US4745124A (en) | Orally effective anti-hypertensive agents | |
| CA2075154A1 (en) | Peptide aldehydes as antithrombotic agents | |
| SI9620037A (sl) | Novi trombinski inhibitorji | |
| WO1993025574A1 (en) | Inhibitors of angiotensin i chymase(s) including human heart chymase | |
| US20020119992A1 (en) | Thrombin inhibitors | |
| US4912120A (en) | 3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors | |
| US4929630A (en) | Transglutaminase inhibitors | |
| US4766110A (en) | Novel complex amido and imido derivatives of carboxyalkyl peptides | |
| JPH10509727A (ja) | Ｎ−末端スルホニル−又はアミノスルホニル基を有する新規のジペプチドのｐ−アミノベンジルアミド | |
| Xie et al. | New kelatorphan-related inhibitors of enkephalin metabolism: improved antinociceptive properties | |
| US5798377A (en) | Thrombin inhibitors | |
| EP0858262B1 (en) | Thrombin inhibitors | |
| JP2004503563A (ja) | 凝固因子Ｘａ阻害剤 | |
| US6693072B2 (en) | Elastase inhibitors | |
| EP0846120A1 (en) | Low molecular weight bicyclic-area type thrombin inhibitors | |
| US7217733B2 (en) | ACE inhibitor derivatives | |
| US4734420A (en) | Anti-hypertensive agents | |
| EP0036713B1 (en) | Angiotensin converting enzyme inhibitors | |
| US6265381B1 (en) | Orally-active elastase inhibitors | |
| US4690936A (en) | Anti-hypertensive agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |